Status: current, Defined. Date: 31-Aug 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2975771000168112 | Irinotecan (Apo) (irinotecan hydrochloride trihydrate 300 mg / 15 mL) injection, 1 x 15 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2975781000168110 | Irinotecan (Apo) 300 mg/15 mL injection, 15 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irinotecan (Apo) 300 mg/15 mL injection, 15 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Irinotecan (Apo) 300 mg/15 mL injection, 15 mL vial | Is a | irinotecan hydrochloride trihydrate 300 mg/15 mL injection, 15 mL vial | true | Inferred relationship | Some | ||
| Irinotecan (Apo) 300 mg/15 mL injection, 15 mL vial | has TPUU | Irinotecan (Apo) 300 mg/15 mL injection, 15 mL vial | true | Inferred relationship | Some | 1 | |
| Irinotecan (Apo) 300 mg/15 mL injection, 15 mL vial | has TP | Irinotecan (Apo) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irinotecan (Apo) 300 mg/15 mL injection, 15 mL vial | Is a | True | Irinotecan (Apo) 300 mg/15 mL injection, 15 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR